110 related articles for article (PubMed ID: 10760569)
1. Allelic expression of the putative tumor suppressor gene p73 in human fetal tissues and tumor specimens.
Hu JF; Ulaner GA; Oruganti H; Ivaturi RD; Balagura KA; Pham J; Vu TH; Hoffman AR
Biochim Biophys Acta; 2000 Apr; 1491(1-3):49-56. PubMed ID: 10760569
[TBL] [Abstract][Full Text] [Related]
2. P73 gene expression in ovarian cancer tissues and cell lines.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Oct; 6(10):3910-5. PubMed ID: 11051237
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p73 in human borderline and invasive ovarian tumor.
Ng SW; Yiu GK; Liu Y; Huang LW; Palnati M; Jun SH; Berkowitz RS; Mok SC
Oncogene; 2000 Apr; 19(15):1885-90. PubMed ID: 10773878
[TBL] [Abstract][Full Text] [Related]
4. Loss of imprinting and allele switching of p73 in renal cell carcinoma.
Mai M; Qian C; Yokomizo A; Tindall DJ; Bostwick D; Polychronakos C; Smith DI; Liu W
Oncogene; 1998 Oct; 17(13):1739-41. PubMed ID: 9796703
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
6. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
7. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma.
Kang MJ; Park BJ; Byun DS; Park JI; Kim HJ; Park JH; Chi SG
Clin Cancer Res; 2000 May; 6(5):1767-71. PubMed ID: 10815895
[TBL] [Abstract][Full Text] [Related]
9. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
Vikhanskaya F; D'Incalci M; Broggini M
Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
[TBL] [Abstract][Full Text] [Related]
10. Activation of p73 silent allele in lung cancer.
Mai M; Yokomizo A; Qian C; Yang P; Tindall DJ; Smith DI; Liu W
Cancer Res; 1998 Jun; 58(11):2347-9. PubMed ID: 9622072
[TBL] [Abstract][Full Text] [Related]
11. Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines.
Kovalev S; Marchenko N; Swendeman S; LaQuaglia M; Moll UM
Cell Growth Differ; 1998 Nov; 9(11):897-903. PubMed ID: 9831242
[TBL] [Abstract][Full Text] [Related]
12. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Kaghad M; Bonnet H; Yang A; Creancier L; Biscan JC; Valent A; Minty A; Chalon P; Lelias JM; Dumont X; Ferrara P; McKeon F; Caput D
Cell; 1997 Aug; 90(4):809-19. PubMed ID: 9288759
[TBL] [Abstract][Full Text] [Related]
13. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers.
Nomoto S; Haruki N; Kondo M; Konishi H; Takahashi T; Takahashi T; Takahashi T
Cancer Res; 1998 Apr; 58(7):1380-3. PubMed ID: 9537234
[TBL] [Abstract][Full Text] [Related]
14. Lack of p73 mutations and late occurrence of p73 allelic deletions in melanoma tissues and cell lines.
Schittek B; Sauer B; Garbe C
Int J Cancer; 1999 Aug; 82(4):583-6. PubMed ID: 10404074
[TBL] [Abstract][Full Text] [Related]
15. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the wild type p73 gene in human bladder cancer.
Yokomizo A; Mai M; Tindall DJ; Cheng L; Bostwick DG; Naito S; Smith DI; Liu W
Oncogene; 1999 Feb; 18(8):1629-33. PubMed ID: 10102633
[TBL] [Abstract][Full Text] [Related]
17. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53.
Cai YC; Yang GY; Nie Y; Wang LD; Zhao X; Song YL; Seril DN; Liao J; Xing EP; Yang CS
Carcinogenesis; 2000 Apr; 21(4):683-9. PubMed ID: 10753204
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers.
Ahomadegbe JC; Tourpin S; Kaghad M; Zelek L; Vayssade M; Mathieu MC; Rochard F; Spielmann M; Tursz T; Caput D; Riou G; Bénard J
Oncogene; 2000 Nov; 19(47):5413-8. PubMed ID: 11103943
[TBL] [Abstract][Full Text] [Related]
19. Frequent allelic losses on the short arm of chromosome 1 and decreased expression of the p73 gene at 1p36.3 in squamous cell carcinoma of the oral cavity.
Araki D; Uzawa K; Watanabe T; Shiiba M; Miyakawa A; Yokoe H; Tanzawa H
Int J Oncol; 2002 Feb; 20(2):355-60. PubMed ID: 11788901
[TBL] [Abstract][Full Text] [Related]
20. p73, a gene related to p53, is not mutated in esophageal carcinomas.
Nimura Y; Mihara M; Ichimiya S; Sakiyama S; Seki N; Ohira M; Nomura N; Fujimori M; Adachi W; Amano J; He M; Ping YM; Nakagawara A
Int J Cancer; 1998 Nov; 78(4):437-40. PubMed ID: 9797131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
